BamSEC and AlphaSense Join Forces
Learn More

Verrica Pharmaceuticals Inc. – Transcripts

NASDAQ: VRCA    
Share price (7/22/26): $5.70    
Market cap (7/22/26): $97.9 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 06/03/26 Verrica Pharmaceuticals Inc., Q1 2026 Earnings Call, May 12, 2026 05/12/26
Earnings Revised 03/11/26 Verrica Pharmaceuticals Inc., Q4 2025 Earnings Call, Mar 11, 2026 03/11/26
CY 2025
Earnings Revised 11/17/25 Verrica Pharmaceuticals Inc., Q3 2025 Earnings Call, Nov 17, 2025 11/17/25
Earnings Revised 08/12/25 Verrica Pharmaceuticals Inc., Q2 2025 Earnings Call, Aug 12, 2025 08/12/25
Earnings Revised 06/16/25 Verrica Pharmaceuticals Inc., Q1 2025 Earnings Call, May 13, 2025 05/13/25
Earnings Revised 03/20/25 Verrica Pharmaceuticals Inc., Q4 2024 Earnings Call, Mar 11, 2025 03/11/25
CY 2024
Earnings Revised 01/21/25 Verrica Pharmaceuticals Inc., Q2 2024 Earnings Call, Aug 14, 2024 08/14/24
Earnings Revised 05/13/24 Verrica Pharmaceuticals Inc., Q1 2024 Earnings Call, May 13, 2024 05/13/24
Earnings Revised 02/29/24 Verrica Pharmaceuticals Inc., Q4 2023 Earnings Call, Feb 29, 2024 02/29/24
CY 2023
Earnings Revised 11/28/23 Verrica Pharmaceuticals Inc., Q3 2023 Earnings Call, Nov 09, 2023 11/09/23
Other Revised 11/24/23 Verrica Pharmaceuticals Inc. - Special Call 10/11/23
Other Revised 07/24/23 Verrica Pharmaceuticals Inc. - Special Call 07/24/23
CY 2021
Other Revised 03/02/21 Verrica Pharmaceuticals Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 11:50 AM 03/02/21
CY 2020
Other Revised 07/14/20 Verrica Pharmaceuticals Inc. - Special Call 07/14/20
Other Revised 03/11/20 Verrica Pharmaceuticals Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2020 04:20 PM 03/11/20
CY 2019
Other Revised 06/27/19 Verrica Pharmaceuticals Inc. - Special Call 06/27/19
Other Revised 05/14/19 Verrica Pharmaceuticals Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 02:35 PM 05/14/19
Other Revised 01/03/19 Verrica Pharmaceuticals Inc. - Special Call 01/03/19